Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
An open-label, dose-adjustment extension study to evaluate the safety and efficacy of
eltrombopag for treatment of subjects with ITP who have previously been enrolled in the
eltrombopag trial TRA108109 (NCT00540423).